๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Jinan 114 Qingdao 7 Yantai 4 Linyi 4 Jining 4
Narrow the registerReset
Recruitment status
Phase
Site location
Jinan114 Qingdao7 Yantai4 Linyi4 Jining4
All 28 locations
Target enrolment
to

Trials with a site in Qingdao

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Prophylactic IABP in Delayed-Presentation Anterior STEMI
NCT07761455Acute Anterior ST-Segment Elevation Myocardial Infarction
Qilu Hospital of Shandong University
Not applicable
504
Jinan, Jining, Qingdao, Beijing
2026-08-01
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
NCT06730373HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma
Qilu Hospital of Shandong University
Phase 2
110
Zhengzhou, Binzhou, Dongying, Jinan, Jining, Liaocheng, Linyi, Qingdao
2024-10-17
Recruiting
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071Bladder Cancer
Qilu Hospital of Shandong University
Observational
293
Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian
2024-10-01
Active, closed
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
NCT06609759Stage II-III Gastric Cancer
Qilu Hospital of Shandong University
Observational
197
Jinan, Qingdao, Yantai
2024-01-01
Active, closed
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
NCT06157216Stage II-III Gastric Cancer
Qilu Hospital of Shandong University
Not applicable
65
Jinan, Qingdao, Yantai
2023-10-01
Active, closed
Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy
NCT05585580Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University
Phase 2
59
Jinan, Qingdao, Yantai, Linyi
2023-03-01
Active, closed
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer
NCT05586061HER2-positive Gastric Cancer
Qilu Hospital of Shandong University
Phase 2
55
Jinan, Qingdao, Yantai
2023-02-10
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Qingdao that also match the filters currently applied.

How many clinical trials are recruiting in Qingdao?

2 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 7 studies
PhaseStudiesRecruitingShare
Phase 23142.9%
Not applicable2028.6%
Observational2128.6%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
Qilu Hospital of Shandong University72
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.